Taspoglutide | acute myocardial infarction, in patients undergoing PCI | vs placebo | all NS | Endpoint | TE [95% CI] | p val | I2 | n | k | |
---|
Trial | Studied treatment | Control | Patients |
---|
HEBE III, 2010 | single bolus of 60,000 IU epoetin alfa administered intravenously within three hours after a successful PCI | control | patients with a first ST-elevation MI and a successful PCI |
| |